Infectious Disease

PrEP simplifies management of the virus by eliminating the need for immune globulin and decreasing the number of doses needed.

Recent study results show that vitamin D may offer protection against critical disease and death.

The National Institutes of Health’s studies aim to research the long-term effects of the coronavirus.

New research results show that patients with mild coronavirus produce antibodies that are able neutralize the infection.

Aaron Clark, DO, medical director of value based care at Ohio State University and clinical associate professor of family medicine, discusses vaccine hesitancy and racial disparities around flu vaccinations.

Study results show that individuals who are unvaccinated are 5 to 7 times more likely to seek medical care because of the predominant strain of the coronavirus.

Results of a new study show that the vaccines seldomly reach the area that were heavily affected by the pandemic, because of ethnic, racial, and socioeconomic disparities.

The results of a study show that with proper antibiotic treatments and therapy, clinical outcomes for those with community-acquired pneumonia do not differ.

Investigators have found bNAbs for HIV, hepatitis C, and influenza, among others.

The agency also advised that fully vaccinated individuals can resume many activities without wearing a mask or social distancing.

Further, while there is ambiguity surrounding the treatment of IBD flare in patients with CDI, case reports suggest corticosteroid initiation after appropriate antibiotic therapy may be effective.

Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.

Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.

With a 1-hour infusion and lower infusion volume, oritavancin could minimize health system costs to treat these infections and improve efficiency in clinical practice.

The increasing prices of the drugs used to treat hookworm, roundworm (ascariasis), and whipworm (trichuriasis) is driving increased costs for patients with Medicaid or private insurance, as well as a potential decrease in the quality of care those patients receive.

Cost-conscious guidelines, government regulation, market-level incentives can ensure access, help patients save money.

The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.

Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.

Originally approved in 2018, baloxavir marboxil is indicated for patients aged 12 years and older.

The new molecules are repurposed form a drug that’s been used for over 80 years.

The objective of the study was to investigate associations between symptoms of gastroenteritis and the presence of airborne norovirus, as well as investigating the size of norovirus-carrying particles.

Study results suggest that infusing foods with green tea extract may lower consumers' chances of catching norovirus when eating contaminated food.

Pharmacists can play an important role in educating patients about hand hygiene measures during COVID-19.

Cefiderocol approved for the treatment with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

What is causing a young, normally healthy person to suddenly fall ill and need immediate medical attention?

The combination of imipenem-cilastatin and relebactam was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.

Remdesivir is not approved by the FDA. However, EUA allows for distribution and emergency use for treatment of COVID-19.

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.